OBCK Share Price Performance
€64.95
-4.05 (-5.87%)
25.8% undervalued intrinsic discount
€87.50
Fair Value
Price €64.95
AnalystConsensusTarget €87.50
Fair Value€87.50
Share Pricen/a
Ottobock SE & Co. KGaA Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
OBCK Community Narratives
AN
Fair Value €87.5 25.8% undervalued intrinsic discount
Neuro Rehabilitation Demand And Reimbursement Expansion Will Drive Long-Term Mobility Solutions Upside
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Neuro Rehabilitation Demand And Reimbursement Expansion Will Drive Long-Term Mobility Solutions Upside
Catalysts About Ottobock SE KGaA Ottobock SE KGaA develops and delivers advanced prosthetics, orthotics, neuro rehabilitation solutions and patient care services worldwide. What are the underlying business or industry changes driving this perspective?Read more
0
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
€87.5
25.8% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
6.88% p.a.
Profit Margin
12.88%
Future PE
31.73x
Price in 2028
€104.53
Trending Discussion
Recently Updated Narratives
AN
Neuro Rehabilitation Demand And Reimbursement Expansion Will Drive Long-Term Mobility Solutions Upside
Fair Value: €87.5 25.8% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Ottobock SE & Co. KGaA Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 19, 2026
- 0.93
- 52.61%
- 3.57%
- 400.1%
About OBCK
- Founded
- 1919
- Employees
- 9256
- CEO
- WebsiteView website
Ottobock SE & Co. KGaA designs and develops medical technology products and solutions for the people with limited mobility in the fields of prosthetics, orthotics, human mobility, and medical care worldwide. The company develops exo-prosthetics products, including microprocessor-controlled lower limb prosthesis systems, bionic prosthetic systems, michelangelo prosthetic hands, and liner and closure systems; temporary fittings for after accidents and injuries; ankle sprains products; fittings for partial paralysis of legs; and mechatronic orthosis systems. It also offers mobility solutions, such as manual and power wheelchairs and rehabilitation products that includes standing supports, seating systems, and seat cushions for active and athletic users. In addition, the company provides patient care and professional workshop management services and professional support services for spatial concepts and area utilization. Ottobock SE & Co. was formerly known as Otto Bock HealthCare GmbH and changed its name to Ottobock SE & Co. KGaA in April 2018. The company was founded in 1919 and is based in Duderstadt, Germany. Ottobock SE & Co. KGaA operates as a subsidiary of Näder Upside 2 Vermögensverwaltungs GmbH.
